If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

Share Price is delayed by 15 minutes
Get Live Data
0.502    0.00 (0.00%)
Bid:
0.51
Ask:
0.518
Spread: 0.008 (1.569%)
Market Cap: $291.83m
IDHC Live PriceLast checked at - London Stock Exchange

Intraday Int Diag Hld Share Chart

Form 8.3 - Integrated Diagnostics Holdings plc

25 Jun 2026 07:00

Vergent Asset Management LLP - Form 8.3 - Integrated Diagnostics Holdings plc

Vergent Asset Management LLP - Form 8.3 - Integrated Diagnostics Holdings plc

PR Newswire

LONDON, United Kingdom, June 25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1.   KEY INFORMATION

(a)   Full name of discloser:

Vergent Asset Management LLP

(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):

  The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:

  Use a separate form for each offeror/offeree

Integrated Diagnostics Holdings plc

(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e)   Date position held/dealing undertaken:

  For an opening position disclosure, state the latest practicable date prior to the disclosure

23/06/2026

(f)   In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

  If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

 

2.   POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)   Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

USD 0.25 ordinary

Interests

Short positions

Number

%

Number

%

(1)   Relevant securities owned and/or controlled:

15,880,812

2.73

(2)   Cash-settled derivatives:

(3)   Stock-settled derivatives (including options) and agreements to purchase/sell:

  TOTAL:

15,880,812

2.73

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)   Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3.   DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a)   Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

COM

Sale

236400

0.5560 USD

(b)   Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c)   Stock-settled derivative transactions (including options)

(i)   Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii)   Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)   Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4.   OTHER INFORMATION

(a)   Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(b)   Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)   the voting rights of any relevant securities under any option; or

(ii)   the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(c)   Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

24/06/2026

Contact name:

Adam Gartland

Telephone number:

604-685-2020

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.



Date   Source Headline
5th Sep 20247:00 amRNSCompletion of EGX Delisting
28th Aug 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSEGX Delisting – buyback under EGX's OPR
23rd Aug 20241:30 pmRNSNotice of Results
13th Aug 20247:00 amRNSEGX Delisting – timeline under EGX's OPR
18th Jul 20243:45 pmRNSResults of Extraordinary General Meeting
1st Jul 20243:40 pmRNSPublication of Circular and Notice of EGM
27th Jun 20247:00 amRNSIDH's proposed revised Delisting Buyback Price
12th Jun 20243:35 pmRNSResults of Extraordinary General Meeting
30th May 20247:00 amRNS1ST QUARTER RESULTS
29th May 20243:44 pmRNSResult of AGM
28th May 202410:42 amRNSNotice of Results
24th May 20244:16 pmRNSPublication of Circular and Notice of EGM
16th May 20247:00 amRNSIDH proposing to delist its shares from the EGX
30th Apr 20242:13 pmRNSNotice of AGM
4th Apr 20241:55 pmRNSAnnual Financial Report
28th Mar 20247:00 amRNSFinal Results
26th Mar 20249:15 amRNSNotice of Results
18th Jan 20244:03 pmRNSIDH appoints Group CFO, VP and Board Member
16th Nov 20237:00 amRNS3rd Quarter Results
25th Oct 20237:00 amRNSIDH CEO increases stake in the Company
17th Oct 20231:56 pmRNSDirector/PDMR Shareholding
16th Oct 202312:26 pmRNSDirector/PDMR Shareholding
13th Oct 20232:02 pmRNSDirector/PDMR Shareholding
12th Oct 202310:33 amRNSDirector/PDMR Shareholding
11th Oct 202310:45 amRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSHalf-year Report
30th Aug 20239:57 amRNSNotice of Results
21st Jun 202311:18 amRNSCFO & Strategic Investment Officer Appointments
14th Jun 20233:01 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNS1st Quarter Results
30th May 20235:49 pmRNSResult of AGM
4th May 20233:03 pmRNSAnnual Financial Report & Notice of AGM
28th Apr 20234:01 pmRNSDirector/PDMR Shareholding
18th Apr 20233:23 pmRNSDirector/PDMR Shareholding
6th Apr 202311:05 amRNSFinal Results
6th Apr 20237:00 amRNSPreliminary Results
4th Apr 20236:10 pmRNSNotice of Results
21st Feb 20234:35 pmRNSPrice Monitoring Extension
6th Feb 20234:40 pmRNSSecond Price Monitoring Extn
6th Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSIDH to no longer pursue acquisition of IDC stake
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20227:00 amRNS3rd Quarter Results
10th Nov 20221:55 pmRNSNotice of Results
31st Oct 202210:06 amRNSIDH launches Greenfield in KSA with Izhoor
5th Oct 20221:09 pmRNSIDH launches sixth Al-Borg Scan Branch
5th Oct 202212:49 pmRNSAl-Borg Scan obtains ACR Accreditation
12th Sep 20228:23 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.